Drug Type CAR-T |
Synonyms CD44v6 CAR T-cells(MolMed) |
Target |
Mechanism CD44v6 inhibitors(CD44v6 inhibitors), T lymphocyte replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Phase 2 | CZ | 27 Aug 2019 | |
Acute Myeloid Leukemia | Phase 2 | IT | 27 Aug 2019 | |
Acute Myeloid Leukemia | Phase 2 | CZ | 27 Aug 2019 | |
Acute Myeloid Leukemia | Phase 2 | IT | 27 Aug 2019 | |
Multiple Myeloma | Phase 2 | IT | 27 Aug 2019 | |
Multiple Myeloma | Phase 2 | CZ | 27 Aug 2019 | |
Multiple Myeloma | Phase 2 | CZ | 27 Aug 2019 | |
Multiple Myeloma | Phase 2 | IT | 27 Aug 2019 |
Phase 1/2 | 8 | zxmeorwcbw(rupjlimhsd) = lapqekxpjq cfhmauxuos (psekhjgjab, ucowktqceu - dsiopmkhyl) View more | - | 19 Jan 2022 |